Commit To Purchase Blueprint Medicines Corp At $55, Earn 14.8% Annualized Using Options

Investors considering a purchase of Blueprint Medicines Corp (BPMC) shares, but tentative about paying the going market price of $69.60/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the April 2019 put at the $55 strike, which has a bid at the time of this writing of $4.60..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.